Astaxanthin-loaded alginate-chitosan gel beads activate Nrf2 and pro-apoptotic signalling pathways against oxidative stress
Hamieh Goshtasbi,Elaheh Dalir Abdolahinia,Marziyeh Fathi,Ali Movafeghi,Hossein Omidian,Jaleh Barar,Yadollah Omidi,Hamieh GoshtasbiElaheh Dalir AbdolahiniaMarziyeh FathiAli MovafeghiHossein OmidianJaleh BararYadollah Omidia Department of Plant,Cell and Molecular Biology,Faculty of Natural Sciences,University of Tabriz,Tabriz,Iranb Research Center for Pharmaceutical Nanotechnology,Biomedicine Institute,Tabriz University of Medical Sciences,Tabriz,Iranc Department of Oral Science and Translation Research,College of Dental Medicine,Nova Southeastern University,Fort Lauderdale,FL,USAd Department of Pharmaceutical Sciences,Barry and Judy Silverman College of Pharmacy,Nova Southeastern University,Fort Lauderdale,FL,USA
DOI: https://doi.org/10.1080/02652048.2024.2319048
2024-02-28
Journal of Microencapsulation
Abstract:Oxidative stress (OS) plays a crucial role in disease development. Astaxanthin (ATX), a valuable natural compound, may reduce OS and serve as a treatment for diseases like neurodegenerative disorders and cancer. Nuclear factor-erythroid 2-related factor 2 (Nrf2) regulates antioxidant enzymes and OS management. We evaluated ATX's antioxidant activity via Alg-CS/ATX gel beads in vitro. ATX-encapsulated alginate-chitosan (Alg-CS/ATX) gel beads were synthesized and structurally/morphologically characterized by SEM, FT-IR, and XRD. Their biological effects were examined in human umbilical vein endothelial cells (HUVECs) treated with H 2 O 2 through MTT assay, Annexin V/PI, cell cycle studies, and western blotting. Alg-CS effectively carried ATX, with high capacity and reduced pore size. Alg-CS/ATX displayed an 84% encapsulation efficiency, maintaining stability for 30 days. In vitro studies showed a 1.4-fold faster release at pH 5.4 than at neutral pH, improving ATX's therapeutic potential. HUVECs treated with Alg-CS/ATX showed enhanced viability via increased Nrf2 expression. Alg-CS gel beads exhibit significant potential as a biocompatible vehicle for delivering ATX to combat OS with considerable opportunity for clinical applications.
pharmacology & pharmacy,chemistry, applied,engineering, chemical